Synopsis of recent research by authors named "Yu-Chun Hsu"
- Yu-Chun Hsu's recent research predominantly focuses on advancements in cancer treatment, particularly in hepatocellular carcinoma (HCC), examining the efficacy of various therapeutic combinations such as lenvatinib/pembrolizumab and atezolizumab/bevacizumab in real-world settings and analyzing the impact of locoregional treatments on patient survival post-systemic therapy failures.
- The author also explores neurological diseases, specifically Alzheimer's disease, utilizing deep learning and neuroimaging techniques to differentiate accelerated cognitive decline associated with the disease from normal aging processes and to identify genetic components influencing this decline.
- Furthermore, Hsu contributes to medical technology through machine learning applications, developing predictive models for acute mortality in emergency department patients using ECG data and investigating non-invasive methods for blood pressure measurement, enhancing healthcare management for chronic disease patients.
